Apellis Pharmaceuticals buy Saftman
Start price
17.03.23
/
50%
€57.93
Target price
17.03.24
-
Performance (%)
3.57%
End price
31.01.24
€60.00
Summary
This prediction ended on 31.01.24 with a price of €60.00. The BUY prediction by Saftman finished with a performance of 3.57%. Saftman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Apellis Pharmaceuticals | - | - | - |
iShares Core DAX® | 1.776% | 3.175% | 14.882% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% |
Comments by Saftman for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Saftman hat das Wertpapier Apellis Pharmaceuticals in seinem Wikifolio Langfristige Aufwärtstrends gekauft.